Ubs Group Ag Medicinova Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Medicinova Inc stock. As of the latest transaction made, Ubs Group Ag holds 305,489 shares of MNOV stock, worth $626,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

305,489

Previous 149 204926.17%

Holding current value

$626,252

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.13 - $2.1 $345,034 - $641,214	305,340 Added 204926.17%	305,489 $641,000
Q2 2024 Aug 13, 2024	SELL	$1.28 - $1.57 $3,024 - $3,709	-2,363 Reduced 94.07%	149 $0
Q1 2024 May 13, 2024	BUY	$1.28 - $1.65 $3,215 - $4,144	2,512 New	2,512 $3,000
Q2 2023 Aug 11, 2023	SELL	$2.09 - $2.43 $111,614 - $129,771	-53,404 Reduced 36.77%	91,828 $211,000
Q1 2023 May 12, 2023	SELL	$1.95 - $2.54 $18,021 - $23,474	-9,242 Reduced 5.98%	145,232 $313,000
Q4 2022 Feb 08, 2023	SELL	$1.97 - $2.66 $58,221 - $78,613	-29,554 Reduced 16.06%	154,474 $316,000
Q2 2022 Aug 10, 2022	SELL	$2.31 - $3.14 $13,656 - $18,563	-5,912 Reduced 3.11%	184,028 $466,000
Q1 2022 May 16, 2022	BUY	$2.19 - $2.81 $1,616 - $2,073	738 Added 0.39%	189,940 $506,000
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.42 $443,517 - $751,090	169,930 Added 881.75%	189,202 $507,000
Q3 2021 Nov 15, 2021	BUY	$3.4 - $4.24 $32,085 - $40,012	9,437 Added 95.95%	19,272 $73,000
Q2 2021 Aug 13, 2021	SELL	$3.76 - $5.14 $37,983 - $51,924	-10,102 Reduced 50.67%	9,835 $42,000
Q1 2021 May 12, 2021	BUY	$4.81 - $8.74 $53,294 - $96,839	11,080 Added 125.1%	19,937 $100,000
Q4 2020 Feb 11, 2021	BUY	$5.03 - $6.31 $10,009 - $12,556	1,990 Added 28.98%	8,857 $47,000
Q3 2020 Nov 12, 2020	SELL	$4.67 - $11.0 $40,456 - $95,293	-8,663 Reduced 55.78%	6,867 $36,000
Q2 2020 Jul 31, 2020	SELL	$3.06 - $7.06 $33,467 - $77,215	-10,937 Reduced 41.32%	15,530 $84,000
Q1 2020 May 01, 2020	SELL	$2.9 - $6.97 $78,157 - $187,848	-26,951 Reduced 50.45%	26,467 $98,000
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $179,515 - $242,678	27,703 Added 107.73%	53,418 $360,000
Q3 2019 Nov 14, 2019	BUY	$7.7 - $10.42 $188,188 - $254,664	24,440 Added 1916.86%	25,715 $205,000
Q2 2019 Aug 14, 2019	SELL	$8.29 - $13.22 $17,898 - $28,541	-2,159 Reduced 62.87%	1,275 $13,000
Q1 2019 May 14, 2019	SELL	$6.82 - $10.27 $18,045 - $27,174	-2,646 Reduced 43.52%	3,434 $29,000
Q4 2018 Feb 14, 2019	SELL	$7.65 - $12.83 $36,735 - $61,609	-4,802 Reduced 44.13%	6,080 $50,000
Q3 2018 Nov 14, 2018	BUY	$7.06 - $12.49 $41,696 - $73,765	5,906 Added 118.69%	10,882 $136,000
Q2 2018 Aug 14, 2018	SELL	$7.96 - $13.23 $17,440 - $28,986	-2,191 Reduced 30.57%	4,976 $40,000
Q1 2018 May 15, 2018	SELL	$6.6 - $13.91 $15,681 - $33,050	-2,376 Reduced 24.9%	7,167 $73,000
Q4 2017 Feb 14, 2018	BUY	$5.89 - $7.21 $5,672 - $6,943	963 Added 11.22%	9,543 $62,000
Q3 2017 Nov 14, 2017	SELL	$4.43 - $6.58 $24,010 - $35,663	-5,420 Reduced 38.71%	8,580 $55,000
Q2 2017 Aug 14, 2017	SELL	N/A	-2,368 Reduced 14.47%	14,000 $74,000
Q1 2017 Nov 14, 2017	BUY	N/A	16,368	16,368 $98,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.83M

Call Options Held

9.4K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $101M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account